The Lyme Disease Network
Medical / Scientific Abstract
|Title:||Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.|
|Authors:||Perides G, Charness ME, Tanner LM, Peter O, Satz N, Steere AC, Klempner MS|
|Source:||J Infect Dis 1998 Feb;177(2):401-8|
JID Home Page: http://www.journals.uchicago.edu/JID/home.html
|Organization:||Tupper Research Institute, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts 02111, USA. email@example.com|
Neurologic manifestations of Lyme disease include meningitis, encephalopathy, and cranial and peripheral neuropathy. There are no sensitive markers for neuroborreliosis, and diagnosis is often based on clinical presentation and cerebrospinal fluid (CSF) abnormalities, including intrathecal antibody production. Matrix metalloproteinase (MMP) activity in CSF was compared in patients with neuroborreliosis, patients with diverse neurologic disorders, and healthy controls. The CSF of 17 of 18 healthy subjects and 33 of 37 patients with neurologic symptoms and normal CSF and imaging studies contained only MMP2. The CSF of several patients with neurologic disorders contained MMP2, MMP9, and gelatinolytic activity at 130 and 250 kDa. The 130-kDa MMP was found without the 92-kDa MMP9 in the CSF of 11 (79%) of 14 patients with neuroborreliosis and only 7 (6%) of 118 control patients (P < .001). This pattern of CSF gelatinase activity may be a useful marker for neuroborreliosis.
Adult, Aged, Chronic Disease, Collagenases, ANALYSIS, CEREBROSPINAL FLUID, METABOLISM, Comparative Study, Female, Gelatinases, ANALYSIS, CEREBROSPINAL FLUID, METABOLISM, Human, Lyme Disease, CEREBROSPINAL FLUID, COMPLICATIONS, DIAGNOSIS, Male, Metalloproteinases, ANALYSIS, CEREBROSPINAL FLUID, METABOLISM, Middle Age, Nervous System Diseases, CEREBROSPINAL FLUID, DIAGNOSIS, MICROBIOLOGY, Support, Non-U.S. Gov't, Support, U.S. Gov't, P.H.S.
Unique ID: 98126004
The Lyme Disease Network of NJ, Inc.
43 Winton Road
East Brunswick, NJ 08816